These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38512446)
1. Sleeve gastrectomy links the attenuation of diabetic kidney disease to the inhibition of renal tubular ferroptosis through down-regulating TGF-β1/Smad3 signaling pathway. Liu C; Zhong M; Jin X; Zhu J; Cheng Y; Li L; Xu Q; Liu Q; Ding H; Zhang G J Endocrinol Invest; 2024 Jul; 47(7):1763-1776. PubMed ID: 38512446 [TBL] [Abstract][Full Text] [Related]
2. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis. Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L Int Immunopharmacol; 2024 Jun; 135():112303. PubMed ID: 38776855 [TBL] [Abstract][Full Text] [Related]
3. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease. Liu J; Ren J; Zhou L; Tan K; Du D; Xu L; Cao W; Zhang Y J Ethnopharmacol; 2024 Nov; 334():118517. PubMed ID: 38972525 [TBL] [Abstract][Full Text] [Related]
4. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway. Jin Z; Gu C; Tian F; Jia Z; Yang J Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304 [TBL] [Abstract][Full Text] [Related]
5. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Kim S; Kang SW; Joo J; Han SH; Shin H; Nam BY; Park J; Yoo TH; Kim G; Lee P; Park JT Cell Death Dis; 2021 Feb; 12(2):160. PubMed ID: 33558472 [TBL] [Abstract][Full Text] [Related]
7. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling. Zhao TT; Zhang HJ; Lu XG; Huang XR; Zhang WK; Wang H; Lan HY; Li P PLoS One; 2014; 9(3):e90807. PubMed ID: 24646636 [TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells. Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466 [TBL] [Abstract][Full Text] [Related]
9. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway. Liu L; Pang X; Shang W; Feng G; Wang Z; Wang J Ren Fail; 2020 Nov; 42(1):513-522. PubMed ID: 32441195 [No Abstract] [Full Text] [Related]
10. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway. Zhang H; Yang Y; Wang Y; Wang B; Li R Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886 [TBL] [Abstract][Full Text] [Related]
11. Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway. Al-Rasheed NM; Al-Rasheed NM; Al-Amin MA; Hasan IH; Al-Ajmi HN; Mohammad RA; Attia HA Arch Physiol Biochem; 2016 Oct; 122(4):186-194. PubMed ID: 26959841 [TBL] [Abstract][Full Text] [Related]
12. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21. Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B Nephron; 2022; 146(1):110-120. PubMed ID: 34724669 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962 [TBL] [Abstract][Full Text] [Related]
14. Indoxyl sulfate enhances p53-TGF-β1-Smad3 pathway in proximal tubular cells. Shimizu H; Yisireyili M; Nishijima F; Niwa T Am J Nephrol; 2013; 37(2):97-103. PubMed ID: 23363842 [TBL] [Abstract][Full Text] [Related]
15. Klotho down-regulates Egr-1 by inhibiting TGF-β1/Smad3 signaling in high glucose treated human mesangial cells. Li Y; Hu F; Xue M; Jia YJ; Zheng ZJ; Wang L; Guan MP; Xue YM Biochem Biophys Res Commun; 2017 May; 487(2):216-222. PubMed ID: 28411025 [TBL] [Abstract][Full Text] [Related]
16. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway. Pang R; Gu D Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice. Wang Y; Lin C; Ren Q; Liu Y; Yang X Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569 [TBL] [Abstract][Full Text] [Related]
18. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN. Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288 [TBL] [Abstract][Full Text] [Related]
19. 2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from the root of Averrhoa carambola L., protects against diabetic kidney disease by inhibiting TLR4/TGFβ signaling pathway. Zhang H; Lu S; Chen L; Huang X; Jiang L; Li Y; Liao P; Wu X; Zhou X; Qin L; Wei J; Huang R Int Immunopharmacol; 2020 Mar; 80():106120. PubMed ID: 31972423 [TBL] [Abstract][Full Text] [Related]
20. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway. Gu LY; Yun-Sun ; Tang HT; Xu ZX J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]